Antidiabetic properties of an Ethanolic leaf extract of Launaea taraxacifolia (Willd.) Amin ex C. Jeffrey (Asteraceae) in SD rats

Clinical Phytoscience

Original Contribution

Emmanuel Kodua¹  Ofosua Adi-Dako²  Joseph Adusei Sarkodie³  Nana Ama Mireku-Gyimah³  Isaac Julius Asiedu-Gyekye⁴  Benoit Banga Nguessan⁴  De-Graft Gyamfi Adjei⁴  Alexander Kwadwo Nyarko⁴  Irene Asare Lartey⁴  Jonathan Komla Amedior⁴ 

[1]Department of Animal Experimentation, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana

[2]Department of Pharmaceutics and Microbiology, University of Ghana School of Pharmacy, Legon, Accra, Ghana

[3]Department of Pharmacognosy and Herbal Medicine, University of Ghana School of Pharmacy, Legon, Accra, Ghana

[4]Department of Pharmacology and Toxicology, University of Ghana School of Pharmacy, Legon, Accra, Ghana

关键词: Diabetes;    Launaea taraxacifolia;    Streptozotocin-nicotinamide;    Gluconeogenesis;    Dyslipidemia;    Fasting glucose;   

DOI  :  10.1186/s40816-022-00350-3

 received in 2021-01-26, accepted in 2022-11-05,  发布年份 2022

来源: Springer

【 摘 要 】

BackgroundDiabetes Mellitus (DM) is a major health problem, with a global prevalence of 9.3%, 4.7% in Africa, and 2.5% in Ghana. Despite the availability of the classic anti-diabetic medications, many patients have not benefited from them due to their poor glycemic controls, high costs, inability to halt disease progression, and untoward side effects. Some patients thus resort to plant-based medicines such as those obtained from L. taraxacifolia etc., which have little empirical evidence of efficacy. Therefore, this study investigated the possible antidiabetic effects of the leaf extracts of L. taraxacifolia and some potential mechanistic targets involved.MethodologyEthanolic extract of L. taraxacifolia leaves (LTE) was screened for phytoconstituents and tested for blood glucose-lowering properties in both non-diabetic and streptozotocin-nicotinamide-induced (STZ-NAD) type-2 model diabetic rats for 4 weeks at doses of 500 mg/kg, 750 mg/kg, and 1000 mg/kg. Metformin (200 mg/kg) and glibenclamide (5 mg/kg) were used as positive controls. Effects of LTE on blood glucose, serum lipids, hepatic gluconeogenesis, intestinal glucose absorption, liver enzymes, oral glucose tolerance, and rat organ weights were all studied. Pancreatic Islet histology was also conducted.ResultsThe ethanolic extract of L. taraxacifolia leaves reduced fasting blood glucose levels and suppressed hyperglycemia during the oral glucose tolerance test. In addition, hepatic gluconeogenesis and intestinal glucose absorption were inhibited. The extract lowered levels of liver enzymes, total cholesterol, and LDL cholesterol while increasing HDL cholesterol levels. Again, it reversed STZ-induced weight changes to the liver, kidneys, and pancreas as well as restored the morphology of the pancreatic Islet of Langerhans.ConclusionLaunaea taraxacifolia leaves extract (LTE) possesses anti-diabetic constituents and has the potential to repair diabetes-induced damages to the liver, kidney, and pancreatic Islets in SD rats.

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

Fig. 2

12951_2022_1749_Article_IEq6.gif

Fig. 3

Fig. 4

12864_2022_9026_Article_IEq187.gif

Fig. 1

Fig. 7

Fig. 1